µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© oeKc-[r
==r|]~x
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© zUu>kJZ
1¡¢Co-stimulators (or co-stimulating molecules) ~n
9DG>a
2¡¢NK-kB &fj?hYAj
3¡¢Immunoglobulin superfamily xT8"+}
4¡¢antigen-presenting cell (APC) LK5H~FK
5¡¢death domain (}8 ;3pp
6¡¢CCR and CXCR Br!&Y9
7¡¢Lectin (or mitogen) <\mc|p"
8¡¢Clusters of differentiation, CD) ?{IvA:
9¡¢B7 family 6p{x2>2y[
10¡¢Cytotoxic T lymphocyte, CTL) 8;NO>L/J]i
11¡¢IL-15 and IL-15 receptor (IL-15R) ![tI(TPq
12¡¢MHC restriction t"Hrn3w
13¡¢Affinity-chromatography h;M2ylOu.
14¡¢Cyctosprin A, CsA l[| e3<H
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) [DEw:%
SLo/7
$rct
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© [40 YoVlfM
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 LeCU"~
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ l$KcS&{w9
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ PEl]HI_H
B E)l77=/
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© $)~]4n=
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ !W7ekPnK
ѪҺ²¡Ñ§×¨Òµ£º N';lc:Ah~
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿